3-methylglutaconic aciduria type 4 (Q101495): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (6 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
A acidúria 3-metilglutacônica tipo IV, ou 3-MGA não classificado, é um distúrbio clinicamente heterogêneo caracterizado por aumento da excreção de ácido 3-metilglutacônico em indivíduos que não podem ser classificados como tendo uma das outras formas de 3-MGA (3 -MGA I, II ou III). Os pacientes geralmente apresentam achados neurológicos durante o primeiro ano de vida, incluindo retardo psicomotor, hipotonia, atraso no desenvolvimento, convulsões e espasticidade progressiva, juntamente com grave insuficiência de crescimento. | |||||||||||||||
| description / en | description / en | ||||||||||||||
3-methylglutaconic aciduria (3-MGA) type IV, or unclassified 3-MGA, is a clinically heterogeneous disorder characterised by increased 3-methylglutaconic acid excretion in individuals that cannot be classified as having one of the other forms of 3-MGA (3-MGA I, II or III). Patients usually present during the first year of life with neurological findings including psychomotor retardation, hypotonia, developmental delay, seizures and progressive spasticity, together with severe failure to thrive. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/185382411 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:ID_185382411 | |||||||||||||||
| Property / CURIE: CID11:ID_185382411 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-ID_185382411 | |||||||||||||||
| Property / Canary Token: dki-india-ID_185382411 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
15 August 2026
| |||||||||||||||
| Property / Collection date: 15 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 18:18, 16 August 2026
3-methylglutaconic aciduria (3-MGA) type IV, or unclassified 3-MGA, is a clinically heterogeneous disorder characterised by increased 3-methylglutaconic acid excretion in individuals that cannot be classified as having one of the other forms of 3-MGA (3-MGA I, II or III). Patients usually present during the first year of life with neurological findings including psychomotor retardation, hypotonia, developmental delay, seizures and progressive spasticity, together with severe failure to thrive.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_185382411 |
||
| English | 3-methylglutaconic aciduria type 4 |
3-methylglutaconic aciduria (3-MGA) type IV, or unclassified 3-MGA, is a clinically heterogeneous disorder characterised by increased 3-methylglutaconic acid excretion in individuals that cannot be classified as having one of the other forms of 3-MGA (3-MGA I, II or III). Patients usually present during the first year of life with neurological findings including psychomotor retardation, hypotonia, developmental delay, seizures and progressive spasticity, together with severe failure to thrive. |
Statements
CID11:ID_185382411
0 references
dki-india-ID_185382411
0 references
Concluído
0 references
15 August 2026
0 references
